Search

Find exactly what you’re looking for.
Search

Service
Showing 61-77 of 77 results
​The FTC has announced the annual updates to the Hart-Scott-Rodino (“HSR”) size thresholds, fees and the daily penalty for HSR violations. The updated thresholds and fees were published in the Federal Register on January 26, 2023 and will take effect on February 27, 2023. See Federal Register...

The use of artificial intelligence (AI) to create works of art creates interesting legal challenges to the protection of intellectual property. A copyright infringement class action lawsuit has been filed against providers of AI software that is used to generate visual works of art based on...

Saul Ewing attorneys, Sean O’Neill and Michael Gold , discuss new ESG regulations in connection with the Real Estate industry and Real Estate Investment Trusts (REITs). New regulations from the U.S. Department of Labor and proposed regulations from the Securities & Exchange Commission have created...

LATEST UPDATE The FTC has voted to extend the public comment period on its proposed rule to ban employers from imposing non-competes on their workers, and will now be accepting comments on the proposed rule until April 19, 2023. Comments can still be submitted in either writing or online using the...

The use of artificial intelligence (AI) in health care, and specifically, as the utilization of software in medical devices continues to increase. Machine learning (ML) is a branch of AI in which computer systems automatically adapt, improve, and make predictions by applying algorithms to analyze...

The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...

Jim Gkonos spoke during a recent webinar hosted by the Association of Insurance Compliance Professionals. The discussion covered Environmental, Social, and Corporate Governance (ESG). The conversation will included an overview of developments with regard to ESG as a driver of insurance company...

Saul Ewing attorneys hosted this fast-paced webinar, providing a list of things you need to know to develop your checklist for legal issues in 2023, from employment, corporate governance, cybersecurity and privacy, intellectual property to tax. Attorneys with specialized knowledge in these areas...

Saul Ewing Real Estate attorneys, Megan Moyer and Frederick Poindexter, moderated a panel discussion on the cost-saving benefits of C-PACE Financing amid efforts to achieve carbon neutrality. Our panel of experts, all of whom were involved in a joint project and represented each aspect of the...

Saul Ewing Partners Andy Bockis, Justin Danilewitz and Sean O'Neill will speak at the 2022 Oil & Gas Law Conference on October 26, 2022. Their topic will be "Will the SEC's Proposed Climate Reporting Rules Survive a Major Questions Challenge."

Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...

New Jersey’s landmark Environmental Justice Law, N.J.S.A. 13:1D-157 (“EJ Law”), signed by Governor Murphy in September 2020, authorizes the NJDEP to deny or condition certain permits based on an assessment of a “facility’s” contribution to environmental and public health impacts in the State’s...

The law firm of Saul Ewing invites you to their 7th Biennial Energy and the Environment Symposium in Houston, Texas. This half-day hybrid MCLE brought together in-house counsel, prominent industry representatives and government officials - virtually and in-person - to share their insights on the...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

For More Information
Contact us